Dr. Glenn Flores Named Chair of Pediatrics at University of Miami Health System/Miller School of Medicine

Glenn Flores, M.D., FAAP, director of the Health Services Research Institute at Connecticut Children’s Medical Center and professor of pediatrics at the University of Connecticut School of Medicine, has been named chair of the Department of Pediatrics at the University of Miami Miller School of Medicine.

Dr. Flores will also serve as senior associate dean for child health, the George E. Batchelor Endowed Chair in Child Health, and physician-in-chief at Holtz Children's Hospital at UM/Jackson Memorial Medical Center.

After graduating magna cum laude from Harvard College, Dr. Flores received his medical degree from the University of California, San Francisco, followed by a residency in pediatrics at the New York Hospital-Cornell Medical Center and a fellowship in the Robert Wood Johnson Clinical Scholars Program at Yale University School of Medicine.

He has served in leadership positions in pediatrics at Boston Medical Center, Medical College of Wisconsin, and the University of Texas Southwestern Medical Center in Dallas, and as distinguished chair of health policy research at the Medical Research Institute in Minneapolis and as a research affiliate at the Mayo Clinic in Rochester, Minnesota.

Dr. Francis Hornicek Named Chair of Department of Orthopaedics at University of Miami Health System and Leader at Sylvester

Francis Hornicek, M.D., Ph.D., has been named chair of the Department of Orthopaedics at the University of Miami Health System and Miller School of Medicine. Dr. Hornicek, who completed his residency at University of Miami/Jackson Memorial Hospital and began his academic career on the Miller School faculty, has served most recently as chair of the Department of Orthopaedic Surgery at the University of California, Los Angeles.

Dr. Hornicek has also been named director of orthopaedic oncology at Sylvester Comprehensive Cancer Center. He will serve as a member of the Sylvester Clinical Research Advisory Board, the Scientific Steering Committee, and the Academic Advisory Council, among other leadership activities. He will work closely with Sylvester Director Stephen D. Nimer, M.D., and Associate Director for Clinical Research Jonathan C. Trent, M.D., Ph.D., to expand sarcoma care and research.

During his distinguished career Dr. Hornicek has also been a faculty member at Harvard Medical School, where he became chief of the Musculoskeletal Oncology Service.

Board-Certified Dermatologist and Mohs Surgeon Sean McGregor, DO, PharmD, Joins Cleveland Clinic Indian River Hospital

Cleveland Clinic Indian River Hospital welcomes board-certified dermatologist and fellowship-trained Mohs surgeon Sean McGregor, D.O.

Dr. McGregor completed a fellowship in Micrographic Surgery and Dermatologic Oncology in association with Mercer University School of Medicine in Macon, Georgia. Prior to fellowship, he completed his dermatology residency at Wake Forest University School of Medicine in North Carolina. He completed his medical training at the Philadelphia College of Osteopathic Medicine, Georgia Campus, in Suwanee, Ga. In addition, he earned a Doctor of Pharmacy degree at the Lloyd L. Gregory School of Pharmacy at Palm Beach Atlantic University prior to his medical training.

Prior to joining Indian River Hospital, Dr. McGregor worked as a dermatologist and Mohs surgeon on the Treasure Coast.

Memorial Healthcare System Appoints Dr. Marc L. Napp as Senior Vice President and Chief Medical Officer

Memorial Healthcare System has appointed to its top medical position Marc L. Napp, M.D., MS, FACS, who will serve as Senior Vice President and Chief Medical Officer.

Dr. Napp previously worked at Mount Sinai Health System in New York, as the Deputy Chief Medical Officer, and the leader of Mount Sinai’s system-wide emergency management program, including the System’s response to COVID-19. Previous to Mount Sinai, Dr. Napp held various medical leadership positions at New York’s Northwell Health and Lenox Hill Hospital, providing oversight for all aspects of medical staff operations. He began his career as an Attending General Surgeon at Surgical Associates of Western Connecticut and Danbury Hospital in Danbury, CT. He has held senior positions in academic, community and integrated healthcare delivery settings, and has extensive experience managing medical staff operations, driving systemness and improving alignment of clinical operations.

Dr. Napp earned his medical degree from the Albert Einstein College of Medicine, an MS in Administrative Medicine from the University of Wisconsin – Madison, and a BSE in Chemical Engineering from Princeton University.

Health Care District Welcomes New Marketing and Branding Manager

The Health Care District of Palm Beach County recently welcomed Juliza Kramer to the new role of Marketing and Branding Manager. In her new role, Kramer will focus on growing the Health Care District’s presence in the community and expanding initiatives to engage current and new patients to the safety net system’s diverse health care services.

“I am excited and humbled by the opportunity to serve our community and spread the word about all of the amazing work the Health Care District has been doing,” said Kramer, who has over ten years of experience in marketing and branding in Palm Beach County. “I look forward to raising awareness about all of the quality services we offer in the county that has always been my home.”

Kramer brings a strong public relations background and experience in both the private and non-profit sectors. The new position is timely as the Health Care District serves in roles never contemplated before the pandemic, such as meeting the need in the community for access to COVID-19 vaccinations and testing.

Palm Beach Gardens Medical Center Announces Appointment of Denise Kvapil to Chief Nursing and Operations Officer

Palm Beach Gardens Medical Center announces the appointment of Denise Kvapil, MSN, BSN, to Chief Nursing and Operations Officer.

Prior to her appointment, Kvapil served as the Chief Nursing Officer at the hospital. In her role, she was responsible for overseeing and coordinating the daily operations of Palm Beach Gardens Medical Center’s nursing departments. She ensured the hospital’s tradition of delivering high quality patient care is, and will continue to be maintained.

Before joining the team at Palm Beach Gardens Medical Center, Kvapil served as the Vice President of Patient Care Operations / Chief Nursing Officer at Christ Hospital in Jersey City, NJ. She has over 25 years of experience in the healthcare field and hospital administration. Kvapil is a graduate of Rutgers University in Newark, New Jersey, and earned her Masters of Science in Nursing from South University.

Lindsay Mendiola Appointed Chief Financial Officer at Kidz Medical Services

Lindsay A. Mendiola, CPA, MBA, CPME, was appointed Chief Financial Officer at KIDZ Medical. She is based at the corporate office in Coral Gables.

Mendiola was a key executive in the development and rapid growth of the Baptist Health Medical Group. Previously, she worked at the NorthShore University Health System and Deloitte Tax LLP in Chicago, IL.

Mendiola received a Master’s in Business Administration in Health Sector Management and Policy from the University of Miami, where she was Valedictorian. She received her undergraduate degree in accountancy, cum laude, from the University of Notre Dame Mendoza College of Business. Ms. Mendiola serves on the boards of The Melissa Institute and the Notre Dame Club of Miami, and is a graduate of the Greater Miami Chamber’s Leadership Miami program.

Jupiter Medical Center Receives $1 Million for Expansion of NICU Services, Programs

Opened in late 2019, the De George Level II Neonatal Intensive Care Unit (NICU) will soon see a program expansion so that Jupiter Medical Center, in partnership with Nicklaus Children’s Hospital, can care for smaller, more vulnerable newborns. Thanks to a generous $1 million gift from The Frank DiMino Family Foundation, Jupiter Medical Center will bolster its programs to care for babies as small as 2.2 pounds.

“We are incredibly grateful for the support from the Frank DiMino Family Foundation,” said Dr. Amit Rastogi, president and CEO of Jupiter Medical Center. “Their generous gift enables us to increase the acuity of care for premature newborns and will change lives in our community.”

Over the past decade, Jupiter Medical Center, in collaboration with Nicklaus Children’s Hospital, has invested heavily in expanding its NICU. The Frank DiMino Family Foundation’s contribution allows the hospital to build out additional, postpartum and antepartum space. The gift also paves the way for increasing subspecialty coverage, and allows Jupiter Medical Center to add a nurse educator to offer nurses PICC certification and to provide support staff with special training. Additionally, the hospital will use the funds to hire an in-house laborist to assist mothers in emergencies when their OB/GYN is enroute to the hospital.

“We are honored to work with Jupiter Medical Center to give newborns and their families access to the best possible care close to home,” said Frank DiMino. These funds will go directly toward providing more life-changing programs and services to support those in need, and ensure they receive quality health care.

Broward Health Medical Center Becomes First Hospital in Florida to Adopt Advanced Genesis Robotic Technology to Treat Heart Rhythm Disorders

Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces that Broward Health Medical Center is establishing a robotic electrophysiology program to expand access to advanced minimally-invasive treatment of heart rhythm disorders in Florida. Broward Health Medical Center will be the only hospital in South Florida offering robotic technology to treat patients suffering from arrhythmias and is the first in Florida, and among the first in the nation, to adopt the latest Genesis Robotic Magnetic Navigation system.

“The adoption of this advanced robotic technology further reinforces the commitment Broward Health Medical Center has toward providing high quality cardiac care for patients suffering from all types of arrhythmias,” said Ahmed Osman, M.D., Medical Director of the Cardiac Electrophysiology Lab. “This technology helps enhance the reach, precision and stability of the traditional tools used in ablation therapy, while having inherent attributes that can increase safety. We are very excited to have access to this technology for our patients.”

Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common, minimally invasive procedure to treat arrhythmias. Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

Broward Health Begins Administering New Combination of Monoclonal Antibody Therapies to Combat COVID-19 Variants

To more effectively treat emerging variants of COVID-19, and in accordance with NIH guidelines, Broward Health has revised its monoclonal antibody therapy and has started using a combination of bamlanivimab and etesevimab, which has been approved by the FDA under an Emergency Use Authorization (EUA). This new combination has shown promising results over the single agent bamlanivimab, which was previously used solely, at addressing COVID-19 infection due to some variants.

“Broward Health continues to explore the most effective treatments for our patients as the COVID-19 virus mutates,” said Joshua Lenchus, D.O., chief medical officer, Broward Health Medical Center. “Monoclonal antibodies have proven effective in preventing COVID-positive patients from getting very sick and requiring hospitalization. But now, as we see the increase in COVID variants affecting our community, we must modify our therapies to ensure the best possible outcomes for our patients.”

Administered together as a diluted intravenous infusion, this new combination can be used for the treatment of mild to moderate COVID-19 in adults and pediatric patients with positive results of direct SARS-CoV-2 viral testing. Patients must be 12 years of age and older weighing at least 40 kg and be at high risk for progressing to severe COVID-19 and/or hospitalization. Monoclonal antibody therapy is available in the outpatient setting.

1 thru 10 out of 17 >>